Literature DB >> 12529710

The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.

Elisabet Einarsdottir1, Ingegerd Söderström, Anna Löfgren-Burström, Susann Haraldsson, Sofie Nilsson-Ardnor, Carlos Penha-Goncalves, Lisbet Lind, Gösta Holmgren, Monica Holmberg, Kjell Asplund, Dan Holmberg.   

Abstract

We have identified a large family in the northern part of Sweden with multiple cases of autoimmune diseases, namely type 1 diabetes (T1D), Graves' disease (GD) and Hashimoto's thyroiditis (HT). The family members affected by any of these diseases share a region of 2.4 Mb that comprises among others the CTLA4 gene. We determined that all affected members of the family shared the HLA susceptibility haplotype (DR4-DQA1*0301-DQB1*0302). Analysis of genetic interaction conditioning for HLA haplotype provided strong evidence that the critical region which includes the CTLA4 gene acts together with the HLA locus on the etiology of disease (lodscore 4.20 (theta=0.0). The study of this family allowed us to: (1) reinforce a number of reports on linkage and association of the CTLA4 region to T1D and AITD; (2) demonstrate that a single haplotypic variant in this region constitutes an etiological factor to disease susceptibility in T1D, GD and HT; (3) reveal a strong genetic interaction of the CTLA4 and HLA loci in the genetic architecture of autoimmune disease; (4) emphasise the value of large pedigrees drawn from isolated populations as tools to single out the effect of individual loci in the etiology of complex diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529710     DOI: 10.1038/sj.ejhg.5200903

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

1.  Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes.

Authors:  Brian Golden; Lara Levin; Yoshiyuki Ban; Erlinda Concepcion; David A Greenberg; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2005-05-31       Impact factor: 5.958

2.  Coexistent autoimmunity in familial type 1 diabetes: increased susceptibility in sib-pairs?

Authors:  Yael Lebenthal; Michal Yackobovitch-Gavan; Liat de Vries; Moshe Phillip; Liora Lazar
Journal:  Horm Res Paediatr       Date:  2011-01-15       Impact factor: 2.852

3.  CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis.

Authors:  Jie Liu; Hong-Xin Zhang
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-05

4.  A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene.

Authors:  J M M Howson; D B Dunger; S Nutland; H Stevens; L S Wicker; J A Todd
Journal:  Diabetologia       Date:  2007-02-14       Impact factor: 10.122

5.  Immunogenetics of Hashimoto's thyroiditis.

Authors:  Dimitry A Chistiakov
Journal:  J Autoimmune Dis       Date:  2005-03-11

6.  The Role of CD14 and CTLA4 Gene Polymorphisms in Risk of Celiac Disease among Patients of Iranian Ethnicity.

Authors:  Mahdi Zamani; Fatemeh Karami; Fariba Shirvani; Laleh Kia-Lashaki; Bizhan Shahbazkhani
Journal:  Cell J       Date:  2014-05-25       Impact factor: 2.479

Review 7.  Genetics of rheumatoid arthritis: GWAS and beyond.

Authors:  Kate McAllister; Stephen Eyre; Gisela Orozco
Journal:  Open Access Rheumatol       Date:  2011-06-07

8.  Association of CD247 (CD3ζ) gene polymorphisms with T1D and AITD in the population of northern Sweden.

Authors:  Dan Holmberg; Karin Ruikka; Petter Lindgren; Mats Eliasson; Sofia Mayans
Journal:  BMC Med Genet       Date:  2016-10-04       Impact factor: 2.103

9.  CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden.

Authors:  Sofia Mayans; Kurt Lackovic; Caroline Nyholm; Petter Lindgren; Karin Ruikka; Mats Eliasson; Corrado M Cilio; Dan Holmberg
Journal:  BMC Med Genet       Date:  2007-02-06       Impact factor: 2.103

Review 10.  Immune checkpoint inhibitors in renal cell carcinoma.

Authors:  Kirsty Ross; Rob J Jones
Journal:  Clin Sci (Lond)       Date:  2017-10-27       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.